Nano Dimension Ltd. (NNDM)

NCM – Real Time Price. Currency in USD

1.38

-0.01 (-0.72%)

At close: Jun 26, 2026, 4:00 PM EDT

1.39

+0.01 (0.72%)

After-hours: Jun 26, 2026, 7:49 PM EDT

16.06.2026

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Companies Provide Additional Color on Infinite's Business Model, Market Opportunity and Capital Plan, and Respond to Murchinson Ltd.'s Letter Companies Provide Additional Color on Infinite's Business Model, Market Opportunity and Capital Plan, and Respond to Murchinson Ltd.'s Letter

15.06.2026

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

TORONTO--(BUSINESS WIRE)--Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) ("Nano" or the "Company"), today commented on Nano's announcement that it has signed a non-binding term sheet with Infinite Epigenetics (“Infinite” or “Infinite Epigenetics”) to form a publicly traded, AI-powered health and diagnostics company.1.

15.06.2026

Nano Dimension Ltd. (NNDM) M&A Call Prepared Remarks Transcript

15.06.2026

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

WALTHAM, Mass., June 15, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”) today announced it has entered into a non-binding term sheet for a proposed business combination (“combination”) with Infinite Epigenetics ™ (“Infinite Epigenetics,” “Infinite”), an artificial intelligence (“AI”)-powered preventive health and diagnostics company building a proprietary biological AI platform to read, interpret, and apply epigenetic signals at scale.

11.06.2026

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?

TORONTO--(BUSINESS WIRE)--Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, “Murchinson” or “we”), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) (“Nano” or the “Company”), today issued the following letter to Nano shareholders. *** Fellow Nano Shareholders, Over the last few weeks and months, we have heard CEO Dave Stehlin repeatedly say that Nano's Board of Directors (the “Board”), led.

05.06.2026

Nano Dimension Issues Letter from Chief Executive Officer, David Stehlin

Company Continues to Move Forward on Three-Phase Strategic Plan to Maximize Long-Term Shareholder Value Company Continues to Move Forward on Three-Phase Strategic Plan to Maximize Long-Term Shareholder Value

27.05.2026

Nano Dimension Announces Sale of MarkForged, Inc. to Stratasys

Accelerating Progress Toward Unlocking and Maximizing Long-Term Shareholder Value Transaction Expected to Reduce Annualized Cash Burn by Approximately $15 Million WALTHAM, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd.

Videos

No Data

There is no data to display

Press releases

16.06.2026

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

15.06.2026

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

15.06.2026

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

11.06.2026

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?

Nano Dimension Ltd. (NNDM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Nano Dimension Ltd. (NNDM)

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Nano Dimension Ltd. (NNDM) M&A Call Prepared Remarks Transcript

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?

Nano Dimension Issues Letter from Chief Executive Officer, David Stehlin

Nano Dimension Announces Sale of MarkForged, Inc. to Stratasys

Videos

No Data

Press releases

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Nano Dimension Ltd. (NNDM) M&A Call Prepared Remarks Transcript

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?

Nano Dimension Issues Letter from Chief Executive Officer, David Stehlin

Nano Dimension Announces Sale of MarkForged, Inc. to Stratasys

Videos

No Data

Press releases

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?

Search stocks

Nano Dimension Ltd. (NNDM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Nano Dimension Ltd. (NNDM)

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Nano Dimension Ltd. (NNDM) M&A Call Prepared Remarks Transcript

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?

Nano Dimension Issues Letter from Chief Executive Officer, David Stehlin

Nano Dimension Announces Sale of MarkForged, Inc. to Stratasys

Videos

No Data

Press releases

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Nano Dimension Ltd. (NNDM) M&A Call Prepared Remarks Transcript

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?

Nano Dimension Issues Letter from Chief Executive Officer, David Stehlin

Nano Dimension Announces Sale of MarkForged, Inc. to Stratasys

Videos

No Data

Press releases

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?